Related Experiment Video
Updated: Jun 10, 2025
05:07
Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines
Published on: June 23, 2019
6.6K
Structure-Activity Relationship of Substituted Pyrazoline Derivatives as Small Molecule Tyrosine Kinase Inhibitors
Saleem Akbar1, Subham Das2, Aman Kumar Mahto1
1Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, Delhi-110062, India.
Current Medicinal Chemistry
|October 18, 2024
Summary
Pyrazolines show promise as tyrosine kinase inhibitors (TKIs) for cancer treatment. Further research into their structure-activity relationships (SAR) could lead to more effective and less harmful anticancer drugs.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Oncology
Background:
- Tyrosine kinase inhibitors (TKIs) are crucial in cancer therapy, targeting specific cell signaling pathways.
- Pyrazolines are of significant interest due to their versatile chemistry and potent TKI activity, making them candidates for novel cancer chemotherapy.
Purpose of the Study:
- To develop highly effective tyrosine kinase inhibitors with minimal toxicity for improved cancer treatment outcomes.
- To review and synthesize current knowledge on pyrazoline analogues as small-molecule TKIs in cancer therapy.
Main Methods:
- Comprehensive literature review of in vitro and in vivo studies.
- Analysis of approved medications and active clinical trials involving pyrazoline-based TKIs.
- Examination of structure-activity relationships (SAR) of pyrazoline derivatives.
Main Results:
- Focus on SAR within the pyrazoline scaffold and its derivatives as TKIs.
- Highlights recent advancements, including patented compounds, approved drugs, and agents in clinical trials.
Conclusions:
- Understanding pyrazoline SAR can facilitate the design of next-generation anticancer drugs.
- Pyrazoline-based therapies hold significant future potential, offering hope in cancer treatment.
Related Concept Videos
01:16Adrenergic Agonists: Chemistry and Structure-Activity Relationship
2.6K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
2.6K
01:26Receptor Tyrosine Kinases
12.4K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
12.4K
01:28Structure-Activity Relationships and Drug Design
622
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
622
01:25Basicity of Heterocyclic Aromatic Amines
5.7K
Heterocyclic amines, where the N atom is a part of an alicyclic system, are similar in basicity to alkylamines. Interestingly, the heterocyclic amine having a nitrogen atom as part of an aromatic ring has much less basicity than its corresponding alicyclic counterpart. For this reason, as presented in Figure 1, piperidine (pKb = 2.8) is significantly more basic than pyridine (pKb = 8.8).
5.7K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
01:00Enzyme-linked Receptors
77.4K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
77.4K